AU2003206749A1 - Diagnostics and therapeutics for diseases associated with the gpr65 receptor - Google Patents

Diagnostics and therapeutics for diseases associated with the gpr65 receptor

Info

Publication number
AU2003206749A1
AU2003206749A1 AU2003206749A AU2003206749A AU2003206749A1 AU 2003206749 A1 AU2003206749 A1 AU 2003206749A1 AU 2003206749 A AU2003206749 A AU 2003206749A AU 2003206749 A AU2003206749 A AU 2003206749A AU 2003206749 A1 AU2003206749 A1 AU 2003206749A1
Authority
AU
Australia
Prior art keywords
gpr65
therapeutics
diagnostics
receptor
diseases associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003206749A
Inventor
Ulf Bruggemeier
Andreas Geerts
Stefan Golz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Publication of AU2003206749A1 publication Critical patent/AU2003206749A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003206749A 2002-02-01 2003-01-20 Diagnostics and therapeutics for diseases associated with the gpr65 receptor Abandoned AU2003206749A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02001943.6 2002-02-01
EP02001943 2002-02-01
PCT/EP2003/000477 WO2003065045A2 (en) 2002-02-01 2003-01-20 Diagnostics and therapeutics for diseases associated with the gpr65 receptor

Publications (1)

Publication Number Publication Date
AU2003206749A1 true AU2003206749A1 (en) 2003-09-02

Family

ID=27635781

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003206749A Abandoned AU2003206749A1 (en) 2002-02-01 2003-01-20 Diagnostics and therapeutics for diseases associated with the gpr65 receptor

Country Status (2)

Country Link
AU (1) AU2003206749A1 (en)
WO (1) WO2003065045A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003267347A1 (en) * 2003-09-10 2005-03-29 Galapagos Genomics N.V. Method of identifying a compound that changes the amyloid-beta precursor protein processing in a cell
WO2008101354A1 (en) * 2007-02-22 2008-08-28 Merck Frosst Canada Ltd Gpr65 as a therapeutic target in allergic airway inflammation
CA2940653A1 (en) * 2014-02-27 2015-09-03 Vijay Kuchroo T cell balance gene expression, compositions of matters and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU714642B2 (en) * 1995-06-06 2000-01-06 Human Genome Sciences, Inc. G-protein receptor HTNAD29
WO1998032858A2 (en) * 1997-01-23 1998-07-30 Schering Corporation Mammalian chemokines; receptors; reagents; uses

Also Published As

Publication number Publication date
WO2003065045A3 (en) 2004-02-19
WO2003065045A2 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
AU2003213559A1 (en) Diagnostics and therapeutics for macular degeneration-related disorders
AU2003214072A1 (en) Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1)
AU2003238339A1 (en) Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
AU2003229735A1 (en) Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr)
AU2003206749A1 (en) Diagnostics and therapeutics for diseases associated with the gpr65 receptor
AU2003205627A1 (en) Diagnostics and therapeutics for diseases associated with gpr72
AU2003273994A1 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43)
AU2003229767A1 (en) Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9)
AU2003240589A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 4 (gpr4)
AU2003250128A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 37 (gpr37)
AU2003240720A1 (en) Diagnostics and therapeutics for diseases associated with somatostatin receptor 5 (sstr5)
AU2003218638A1 (en) Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
AU2003283427A1 (en) Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1)
GB0326784D0 (en) Biofedelic seating apparatus with binaural acoustical sensing
AU2003229753A1 (en) Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8)
AU2003276106A1 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12)
AU2003229736A1 (en) Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1)
AU2003240639A1 (en) Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 3 (avpr3)
AU2003227751A1 (en) Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 1 (avpr1)
AU2003245981A1 (en) Diagnostics and therapeutics for diseases associated with the g2a-receptor (g2a)
AU2003240721A1 (en) Diagnostics and therapeutics for diseases associated with somatostatin receptor 4(sstr4)
AU2003233348A1 (en) Seat sensor
AU2003250165A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 19 (gpr19)
AU2003216866A1 (en) Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
AU2003301892A1 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 3 (gpr3)

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase